Actively Recruiting
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
250
Participants Needed
3
Research Sites
372 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).
CONDITIONS
Official Title
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period.
- Informed consent acquisition.
You will not qualify if you...
- none
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
IRCCS - Azienda ospedaliero-universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
2
IRCCS - Azienda ospedaliero-universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
3
IRCCS - Azienda ospedaliero-universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
M
Marco Masetti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here